Immediate Impact
23 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
2025 Standout
Works of Matthew Lastrapes being referenced
The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA -Mutant Breast Cancer Brain Metastases
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Matthew Lastrapes | 38 | 27 | 29 | 4 | 63 | |
| Joana L. Mora | 44 | 43 | 33 | 3 | 88 | |
| Sonja J. Gill | 53 | 56 | 14 | 5 | 79 | |
| Laura Fankhauser | 30 | 18 | 18 | 2 | 49 | |
| Veerin R. Sirihorachai | 33 | 42 | 9 | 3 | 64 | |
| Filomena Di Giacomo | 45 | 28 | 33 | 4 | 66 | |
| Pierre Painsec | 26 | 28 | 18 | 4 | 47 | |
| Suzanne Allan | 38 | 29 | 16 | 4 | 62 | |
| Jaimie Heldstab | 33 | 35 | 22 | 6 | 60 | |
| Lara Absil | 24 | 19 | 8 | 5 | 68 | |
| Kenneth Eng | 26 | 15 | 24 | 5 | 73 |
All Works
Login with ORCID to disown or claim papers
Loading papers...